A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

Completed · Not applicable

Conditions studied: Fecal Incontinence

In brief

Multi-center, prospective, within-subject control, open label clinical trial to evaluate the durability of the safety and effectiveness of the Eclipse™ System after 3 and 12 months of use.

Key facts

Study ID

NCT02428595

Run by

Pelvalon, Inc.

People needed

137

Starts

2015-05-15

Expected to finish

2018-07-18

Last updated by the study team

2019-09-24

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• University of Alabama — Birmingham, Alabama, United States
• Massachusetts General Hospital (MGH) — Boston, Massachusetts, United States
• University of New Mexico — Albuquerque, New Mexico, United States
• University of North Carolina — Raleigh, North Carolina, United States
• Christ Hospital — Cincinnati, Ohio, United States
• University of Oklahoma — Oklahoma City, Oklahoma, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Brown University (WIHRI) — Providence, Rhode Island, United States
• Houston Methodist — Houston, Texas, United States
• Providence Sacred Heart — Spokane, Washington, United States
• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.